Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia

Introduction: Treatment resistant schizophrenia (TRS), affecting approximately one-third of patients with schizophrenia, is associated with a serious impairment in global psychosocial functioning. Clozapine is the only licensed drug for TRS. However its prescription remains limited by its side effec...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Amina Aissa, Rahma Jouini, Uta Ouali, Yosra Zgueb, Fethi Nacef, Zouhaier El Hechmi
Format: article
Langue:EN
Publié: Elsevier 2022
Sujets:
Accès en ligne:https://doaj.org/article/7feafd787a884556b7db28dda7fe9cc6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!